Ultralife Co. (NASDAQ:ULBI) Shares Purchased by Barclays PLC

Barclays PLC increased its position in shares of Ultralife Co. (NASDAQ:ULBI) by 21.3% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 13,395 shares of the technology company’s stock after buying an additional 2,355 shares during the quarter. Barclays PLC’s holdings in Ultralife were worth $121,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Geode Capital Management LLC boosted its stake in shares of Ultralife by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 232,681 shares of the technology company’s stock worth $2,104,000 after acquiring an additional 2,835 shares in the last quarter. Janney Montgomery Scott LLC raised its holdings in Ultralife by 2.4% in the 3rd quarter. Janney Montgomery Scott LLC now owns 443,150 shares of the technology company’s stock worth $4,006,000 after purchasing an additional 10,450 shares during the period. Rhumbline Advisers boosted its position in Ultralife by 1,728.3% during the second quarter. Rhumbline Advisers now owns 11,811 shares of the technology company’s stock worth $125,000 after purchasing an additional 11,165 shares in the last quarter. Juncture Wealth Strategies LLC acquired a new stake in Ultralife in the third quarter valued at approximately $165,000. Finally, Jane Street Group LLC purchased a new stake in shares of Ultralife in the third quarter valued at approximately $166,000. Institutional investors and hedge funds own 30.68% of the company’s stock.

Ultralife Price Performance

NASDAQ:ULBI opened at $8.22 on Friday. The stock has a 50 day moving average of $7.60 and a two-hundred day moving average of $9.04. Ultralife Co. has a 12 month low of $6.63 and a 12 month high of $13.39. The firm has a market cap of $136.67 million, a P/E ratio of 14.95 and a beta of 0.96. The company has a current ratio of 3.30, a quick ratio of 1.62 and a debt-to-equity ratio of 0.04.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on ULBI shares. StockNews.com lowered Ultralife from a “strong-buy” rating to a “buy” rating in a research report on Thursday, October 3rd. Benchmark reaffirmed a “buy” rating and set a $14.00 price objective on shares of Ultralife in a report on Friday, November 15th.

Ultralife Company Profile

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.